ST1571: A paradigm for clinical trials of molecularly targeted agents

B. J. Druker

doi:10.1016/S0753-3322(01)00137-8

ST1571: A paradigm for clinical trials of molecularly targeted agents

B. J. Druker

Knight Cancer Institute

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	529-530
Number of pages	2
Journal	Biomedicine and Pharmacotherapy
Volume	55
Issue number	9-10
DOIs	https://doi.org/10.1016/S0753-3322(01)00137-8
State	Published - 2001

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1016/S0753-3322(01)00137-8

Cite this

@article{115f55339e0c4660a4284c31646c6316,

title = "ST1571: A paradigm for clinical trials of molecularly targeted agents",

author = "Druker, {B. J.}",

year = "2001",

doi = "10.1016/S0753-3322(01)00137-8",

language = "English (US)",

volume = "55",

pages = "529--530",

journal = "Biomedicine and Pharmacotherapy",

issn = "0753-3322",

publisher = "Elsevier Masson",

number = "9-10",

}

TY - JOUR

T1 - ST1571

T2 - A paradigm for clinical trials of molecularly targeted agents

AU - Druker, B. J.

PY - 2001

Y1 - 2001

UR - http://www.scopus.com/inward/record.url?scp=0035652202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035652202&partnerID=8YFLogxK

U2 - 10.1016/S0753-3322(01)00137-8

DO - 10.1016/S0753-3322(01)00137-8

M3 - Article

C2 - 11769961

AN - SCOPUS:0035652202

SN - 0753-3322

VL - 55

SP - 529

EP - 530

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

IS - 9-10

ER -

ST1571: A paradigm for clinical trials of molecularly targeted agents

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this